Frontlight ResearchEarly access
Trial site
Kumamoto Shinto General Hospital
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)4 trials
- Myeloproliferative neoplasms4 trials
- Metastatic breast cancer3 trials
- Hepatitis B1 trial
- Liver cirrhosis1 trial
- Lupus (SLE)1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 37 trials
- Phase 24 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting5 trials
- Active, not recruiting3 trials
- Completed3 trials
- Terminated2 trials
- Lead sponsor
- Incyte Corporation4 trials
- Eli Lilly and Company3 trials
- Boehringer Ingelheim2 trials
- Eisai Co., Ltd.1 trial
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Recruiting
A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer
Recruiting
A Study of E6742 in Participants With Systemic Lupus Erythematosus
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)3 recruiting
- Liver cirrhosis1 recruiting
- Lupus (SLE)1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Terminated
Terminated
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Site data: ClinicalTrials.govUpdated 12 Nov 2026